Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read More

Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read More
In a landmark study published on October 3 in the journal Nature Neuroscience, researchers from the Montefiore Einstein Comprehensive Cancer…
Read More
A groundbreaking study by Stanford Medicine researchers has unveiled a novel immunotherapy approach that could revolutionize the treatment of solid…
Read More
The traditional understanding of glioblastoma—a devastating and primary form of brain cancer—has long characterized the disease as a localized phenomenon,…
Read More
The findings from a landmark study conducted by researchers at the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert…
Read More